INSPIRATION HEALTHCARE GROUP PLC

Environmental & Social Information • Mar 25, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4633H

Inspiration Healthcare Group PLC

25 March 2020

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Patent granted for Project Wave

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that it has received confirmation that the technology for "Project Wave" has been granted a patent by the US Patent Office.

Inspiration entered into a  licence agreement in 2019 with a major US West Coast University to develop "Project Wave" a novel technology for a respiratory device designed for use in neonatal intensive care.  

Neil Campbell, Inspiration Healthcare's CEO commented, "This is a big milestone, knowing we have greater IP protection gives us more confidence as we move the project forward.  We continue to work diligently towards applying for a small clinical trial for this ground breaking technology which we hope to start in the summer."

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Mike Briant, Chief Financial Officer	Tel: 01455 840555
Nominated Adviser & Broker Cenkos Securities plc Mark Connelly Stephen Keys Cameron MacRitchie	Tel: 0207 397 8900
Cadogan PR     Alex Walters alex.walters@cadoganpr.com	Tel: 07771 713608

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRAEAPDLAAPEEFA